[Long-term administration of tyquanol in the treatment of patients with ischemic heart disease in combination with hyperlipidemia].
33 patients with coronary heart disease and hyperlipidemia took tyquanol for 6 months. Tyquanol is a complex of biologically active substances represented by polyunsaturated fatty acids, antioxidants and polyvitamins produced of dietary oils of the sea and plant origin. As a result of the treatment with tyquanol cholesterol, beta-lipoproteins, triglycerides lowered by 16.1, 11.1, 26.3%, respectively. Alphipoproteins rose by 8.8%. A negative effect on hepatic, renal functions or electrolyte composition was not observed.
Panchenko
V M
VM
Ershov
A A
AA
Isaev
V A
VA
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000209:etiology*; D013997:Time Factors; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood; D014815:Vitamins / Q000627:therapeutic use*
D000975:Antioxidants; D004338:Drug Combinations; D005231:Fatty Acids, Unsaturated; D000960:Hypolipidemic Agents; D008055:Lipids; D008077:Lipoproteins, LDL; D014280:Triglycerides; D014815:Vitamins
Dolgosrochnoe primenenie Tykvéĭnola v lechenii bol'nykh ishemicheskoĭ bolezn'iu serdtsa v sochetanii s giperlipidemieĭ.